The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
Open accessAbstract
BACKGROUND: Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Gonadotropin-releasing hormone (GnRH) agonists present an alternative to HCG in controlled ovarian hyperstimulation (COH) treatment regimens in which the cycle has been down-regulated with a GnRH antagonist. This is an update of a review first published in 2010. OBJECTIVES: To evaluate the effectiveness and safety of GnRH agonists in comparison with HCG for triggering final oocyte maturation in IVF and ICSI for women undergoing COH in a GnRH antagonist protocol. SEARCH METHODS: We searched databases including the Menstrual Disorders and Subfertility Group (MDSG) Specialised Register of Controlled Trials, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and trial registers for published and unpublished articles (in any language) on randomised controlled trials (RCTs) of gonadotropin-releasing hormone agonists versus HCG for oocyte triggering in GnRH antagonist IVF/ICSI treatment cycles. The search is current to 8 September 2014. SELECTION CRITERIA: RCTs that compared the clinical outcomes of GnRH agonist triggers versus HCG for final oocyte maturation triggering in women undergoing GnRH antagonist IVF/ICSI treatment cycles were included. DATA COLLECTION AND ANALYSIS: Two or more review authors independently selected studies, extracted data and assessed study risk of bias. Treatment effects were summarised using a fixed-effect model, and subgroup analyses were conducted to explore potential sources of heterogeneity. Treatment effects were expressed as mean differences (MDs) for continuous outcomes and as odds ratios (ORs) for dichotomous outcomes, together with 95% confidence intervals (CIs). Primary outcomes were live birth and rate of ovarian hyperstimulation syndrome (OHSS) per women randomised. Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methods were used to assess the quality of the evidence for each comparison. MAIN RESULTS: We included 17 RCTs (n = 1847), of which 13 studies assessed fresh autologous cycles and four studies assessed donor-recipient cycles. In fresh autologous cycles, GnRH agonists were associated with a lower live birth rate than was seen with HCG (OR 0.47, 95% CI 0.31 to 0.70; five RCTs, 532 women, I(2) = 56%, moderate-quality evidence). This suggests that for a woman with a 31% chance of achieving live birth with the use of HCG, the chance of a live birth with the use of an GnRH agonist would be between 12% and 24%.In women undergoing fresh autologous cycles, GnRH agonists were associated with a lower incidence of mild, moderate or severe OHSS than was HCG (OR 0.15, 95% CI 0.05 to 0.47; eight RCTs, 989 women, I² = 42%, moderate-quality evidence). This suggests that for a woman with a 5% risk of mild, moderate or severe OHSS with the use of HCG, the risk of OHSS with the use of a GnRH agonist would be between nil and 2%.In women undergoing fresh autologous cycles, GnRH agonists were associated with a lower ongoing pregnancy rate than was seen with HCG (OR 0.70, 95% CI 0.54 to 0.91; 11 studies, 1198 women, I(2) = 59%, low-quality evidence) and a higher early miscarriage rate (OR 1.74, 95% CI 1.10 to 2.75; 11 RCTs, 1198 women, I² = 1%, moderate-quality evidence). However, the effect was dependent on the type of luteal phase support provided (with or without luteinising hormone (LH) activity); the higher rate of pregnancies in the HCG group applied only to the group that received luteal phase support without LH activity (OR 0.36, 95% CI 0.21 to 0.62; I(2) = 73%, five RCTs, 370 women). No evidence was found of a difference between groups in risk of multiple pregnancy (OR 3.00, 95% CI 0.30 to 30.47; two RCTs, 62 women, I(2) = 0%, low-quality evidence).In women with donor-recipient cycles, no evidence suggested a difference between groups in live birth rate (OR 0.92, 95% CI 0.53 to 1.61; one RCT, 212 women) or ongoing pregnancy rate (OR 0.88, 95% CI 0.58 to 1.32; three RCTs, 372 women, I² = 0%). We found evidence of a lower incidence of OHSS in the GnRH agonist group than in the HCG group (OR 0.05, 95% CI 0.01 to 0.28; three RCTs, 374 women, I² = 0%).The main limitation in the quality of the evidence was risk of bias associated with poor reporting of methods in the included studies. AUTHORS' CONCLUSIONS: Final oocyte maturation triggering with GnRH agonist instead of HCG in fresh autologous GnRH antagonist IVF/ICSI treatment cycles prevents OHSS to the detriment of the live birth rate. In donor-recipient cycles, use of GnRH agonists instead of HCG resulted in a lower incidence of OHSS, with no evidence of a difference in live birth rate.Evidence suggests that GnRH agonist as a final oocyte maturation trigger in fresh a
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Ovarian Hyperstimulation Syndrome: An Update Review
GOLAN, A., RON-EL, R., HERMAN, A., & SOFFER, Y. (1989) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198906000-00004 · Cited by 806
Bias in meta-analysis detected by a simple, graphical
Stuck, A. E., Rubenstein, L. Z., Wieland, D., Vandenbroucke, J. P., Irwig, L., Macaskill, P., Berry, G., Glasziou, P., Seagroatt, V., Stratton, I., et al. (1998) · BMJ · doi:10.1136/bmj.316.7129.469 · Cited by 699
Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment
Wallach, E. E., Navot, D., Bergh, P. A., & Laufer, N. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55188-7 · Cited by 621
Industry sponsorship and research outcome
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub2 · Cited by 605
Grey literature in meta-analyses of randomized trials of health care interventions
Hopewell, S., McDonald, S., Clarke, M. J., & Egger, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000010.pub3 · Cited by 598
Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy
Song, F., Khan, K. S., Dinnes, J., & Sutton, A. J. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.88 · Cited by 484
Humaidan, P., Ejdrup Bredkjær, H., Bungum, L., Bungum, M., Grøndahl, M. L., Westergaard, L., & Yding Andersen, C. (2005) · Human Reproduction · doi:10.1093/humrep/deh765 · Cited by 484
Engmann, L., DiLuigi, A., Schmidt, D., Nulsen, J., Maier, D., & Benadiva, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.002 · Cited by 422
Simon, C., Cano, F., Valbuena, D., Remohi, J., & Pellicer, A. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136313 · Cited by 348
Fauser, B. C. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.709 · Cited by 343
Valbuena, D., Martin, J., de Pablo, J. L., Remohı́, J., Pellicer, A., & Simón, C. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02018-0 · Cited by 328
Beckers, N. G. M., Macklon, N. S., Eijkemans, M. J., Ludwig, M., Felberbaum, R. E., Diedrich, K., Bustion, S., Loumaye, E., & Fauser, B. C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021953 · Cited by 307
Handsearching versus electronic searching to identify reports of randomized trials
Hopewell, S., Clarke, M. J., Lefebvre, C., & Scherer, R. W. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000001.pub2 · Cited by 247
Time to publication for results of clinical trials
Hopewell, S., Clarke, M. J., Stewart, L., & Tierney, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000011.pub2 · Cited by 243
The pathophysiology of ovarian hyperstimulation syndrome--views and ideas
Elchalal, U., & Schenker, J. G. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1129 · Cited by 241
Simón, C., Garcia Velasco, J. J., Valbuena, D., Peinado, J. A., Moreno, C., Remohí, J., & Pellicer, A. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00140-x · Cited by 235
Humaidan, P., Polyzos, N. P., Alsbjerg, B., Erb, K., Mikkelsen, A. L., Elbaek, H. O., Papanikolaou, E. G., & Andersen, C. Y. (2013) · Human Reproduction · doi:10.1093/humrep/det249 · Cited by 213
Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation
Forman, R., Belaisch-Allart, J., Fries, N., Hazout, A., Testart, J., & Frydman, R. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59661-7 · Cited by 191
Babayof, R., Margalioth, E. J., Huleihel, M., Amash, A., Zylber-Haran, E., Gal, M., Brooks, B., Mimoni, T., & Eldar‐Geva, T. (2006) · Human Reproduction · doi:10.1093/humrep/dei475 · Cited by 170
Lin, M.-H., Shao-Ying Wu, F., Kuo-Kuang Lee, R., Li, S.-H., Lin, S.-Y., & Hwu, Y.-M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.07.1976 · Cited by 159
Griesinger, G., von Otte, S., Schroer, A., Ludwig, A. K., Diedrich, K., Al‐Hasani, S., & Schultze-Mosgau, A. (2007) · Human Reproduction · doi:10.1093/humrep/dem006 · Cited by 137
Self-citationImpact of ovarian stimulation on corpus luteum function and embryonic implantation
Tavaniotou, A., Albano, C., Smitz, J. E. J., & Devroey, P. (2002) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(01)00134-6 · Cited by 125
Bodri, D., Guillén, J. J., Galindo, A., Mataró, D., Pujol, A., & Coll, O. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.049 · Cited by 123
Schachter, M. E., Friedler, S., Ron-El, R., Zimmerman, A. L., Strassburger, D., Bern, O., & Raziel, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1316 · Cited by 109
Kummer, N., Feinn, R., Griffin, D. W., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des361 · Cited by 107
Griesinger, G., Kolibianakis, E. M., Papanikolaou, E. G. E., Diedrich, K., Steirteghem, A. V., Devroey, P., Bredkjær, H. E., & Humaidan, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.006 · Cited by 106
Self-citationOlivennes, F. J., Fanchin, R. R. F., Bouchard, P., Taieb, J., & Frydman, R. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58404-0 · Cited by 100
Youssef, M. A. F. M., van der Veen, F., Al-Inany, H. G., Griesinger, G., Mochtar, M. H., Aboulfoutouh, I., Khattab, S. M., & van Wely, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008046.pub3 · Cited by 86
Self-citationGalindo, A., Bodri, D., Guillén, J. J., Colodrón, M., Vernaeve, V., & Coll, O. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802404013 · Cited by 78
GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS
Engmann, L., Siano, L. J., Schmidt, D., NULSEN, J. C., MAIER, D. B., & Benadiva, C. A. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60653-0 · Cited by 75
Bodri, D., Guillén, J. J., Trullenque, M., Schwenn, K., Esteve, C. P., & Coll, O. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.08.036 · Cited by 62
Publication bias in clinical trials
Hopewell, S., Dickersin, K., Clarke, M. J., Oxman, A. D., & Loudon, K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000006.pub2 · Cited by 60
Herrero, L., Pareja, S., Losada, C., Cobo, A. C., Pellicer, A., & García-Velasco, J. A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.040 · Cited by 51
Youssef, M. A. F. M., van der Veen, F., Al-Inany, H. G., Griesinger, G., Mochtar, M. H., & van Wely, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008046.pub2 · Cited by 49
Self-citationAgonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos
García-Velasco, J. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.12.010 · Cited by 43
Venous thrombosis during assisted reproduction: Novel risk reduction strategies
Nelson, S. M. (2013) · Thrombosis Research · doi:10.1016/s0049-3848(13)00023-6 · Cited by 38
García-Velasco, J. A., Motta, L., López, A., Mayoral, M., Cerrillo, M., & Pacheco, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.035 · Cited by 32
Kol, S., Homburg, R., Alsbjerg, B., & Humaidan, P. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01399.x · Cited by 16
Kaur, H., Krishna, D., Shetty, N., Krishnan, S., Srinivas, M. S., & Rao, K. A. (2012) · Europe PMC (PubMed Central) · Cited by 4
Cited by
Cancer and fertility preservation: international recommendations from an expert meeting
Lambertini, M., Del Mastro, L., Pescio, M. C., Andersen, C. Y., Azim, H. A., Peccatori, F. A., Costa, M., Revelli, A., Salvagno, F., Gennari, A., et al. (2016) · BMC Medicine · doi:10.1186/s12916-015-0545-7 · Cited by 781
Rienzi, L., Gracia, C., Maggiulli, R., LaBarbera, A. R., Kaser, D. J., Ubaldi, F. M., Vanderpoel, S., & Racowsky, C. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw038 · Cited by 729
ESHRE guideline: ovarian stimulation for IVF/ICSI†
The ESHRE Guideline Group on Ovarian Stimulation, Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., Kunicki, M., La Marca, A., Lainas, G., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa009 · Cited by 543
Self-citationOvarian reserve testing: a user’s guide
Tal, R., & Seifer, D. B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.027 · Cited by 510
Gonadotropin-Releasing Hormone and Its Analogues
Kovacs, P. (2020) · Textbook of Assisted Reproduction · doi:10.1007/978-981-15-2377-9_8 · Cited by 422
Metadata
- Authors
- Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-10-31
- Volume
- 2014
- Issue
- 10
- Pages
- CD008046-CD008046
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2117814169
- Cited by
- 426
- References
- 42
- FWCI
- 37.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.